Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 12, 1997

View Archived Issues

Vical: Q3 1997 highlights

ICN: Q3 1997 highlights

Astra: Q3 and nine-month 1997 highlights

Spotlight on topoisomerase I inhibitors

P&U's Genotropin approved by FDA for adult growth hormone deficiency

FDA approves Intron A for non-Hodgkin's lymphoma

OP-1 exhibits protective effects against kidney damage

Dura submits NDA for Albuterol Spiros

ArQule, ViroPharma to collaborate on antiviral drugs

New neuroprotectants disclosed by Nippon Shinyaku

MDR-reversing agents reported by Nikken Chemicals

Radicicol derivatives with antitumor activity from Sankyo

Chugai discloses nitrovasodilators for angina, restenosis

Mitsui Toatsu reveals novel antitumor agents

Pola's newest antifungal agents disclosed in patent literature

Palatin obtains rights to new ED diagnostic/therapeutic

SKB to fund antiinfective research at Australian university

BioChem Pharma moves cell culture-based influenza vaccine to phase II/III

Preclinical profile of HMR's new KATP channel blocker

The selective PDE V inhibitor EMD-82639 shows potential in coronary insufficiency

New class of TNF-alpha inhibitors safe and well tolerated in phase I

C921-78: a new factor Xa antagonist prevents thrombosis with reduced blood loss

Potent and selective fibrinogen receptor antagonist presented by DuPont Merck

Nonpeptide alphav/beta3 antagonist effective in rabbit model of neointima formation

Tedisamil demonstrates favorable activity in patients with angina

New NHE inhibitor (EMD-85131) shows promise for ischemic heart disease

Amiodarone derivative may be suitable for long-term use

FDA review of Myotrophin continues after resubmission

PDE IV inhibitor from Almirall does not stimulate gastric acid secretion in rats

New guidelines for treating hypertension

Lerisetron: a potent, selective, long-acting and orally effective 5-HT3 antagonist

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...